Rothblatt Martine A
Chairperson &CEO
1 company
Insider Signal Score
58
GoodTrades Analyzed
296
12M Win Rate
53.6%
Avg 3M Return
-6.6%
Avg 12M Return
-1.6%
Rothblatt Martine A is a Chairperson &CEO at United Therapeutics Corporation. Recent SEC Form 4 filings include 0 buys and 118 sells.
Estimated insider holdings value: $26.6M based on current market prices.
Holdings by Company
UTHRApr 20, 2026
Current Shares46.8K
Value$26.63M
Net Activity-320,269
Bought: 0Sold: 320.3K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $577.83 | $5,489,423.82 | -1.5% | - | - | |
| Mar 16, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $537.81 | $5,109,148.28 | -16.5% | - | - | |
| Mar 11, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $539.54 | $5,125,646.80 | -14.7% | - | - | |
| Mar 10, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 10,704 | $539.57 | $5,775,539.58 | -12.8% | - | - | |
| Mar 4, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 19,000 | $317.97 | $6,041,413.58 | -30.9% | - | - | |
| Mar 3, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $499.42 | $4,744,466.67 | -11.5% | - | - | |
| Mar 2, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,779 | $515.75 | $5,043,486.48 | -13.0% | - | - | |
| Dec 19, 2025 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 10,000 | $505.38 | $5,053,778.45 | -54.3% | +1.9% | - | |
| Dec 16, 2025 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 8,000 | $494.09 | $3,952,688.90 | -56.5% | +6.9% | - | |
| Dec 12, 2025 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 8,000 | $487.33 | $3,898,661.73 | -54.9% | +7.9% | - |
Page 1Next →